Sources Methodology

We prioritize primary and higher-quality institutional sources wherever possible, especially for safety, regulatory, and evidence-summary claims.

Source hierarchy

1. FDA, FTC, NIH ODS, NCCIH, MedlinePlus, and similar institutional sources
2. Systematic reviews and meta-analyses
3. Higher-quality randomized trials and review articles
4. Public discussion sources only for anecdotal context and user-language